Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives.

Valent P, Oude Elberink JNG, Gorska A, Lange M, Zanotti R, van Anrooij B, Bonifacio M, Bonadonna P, Gleixner KV, Hadzijusufovic E, Perkins C, Hartmann K, Illerhaus A, Merante S, Elena C, Shoumariyeh K, von Bubnoff N, Parente R, Triggiani M, Schwaab J, Jawhar M, Caroppo F, Fortina AB, Brockow K, David Fuchs, Greul R, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Sabato V, Aberer E, Al-Ali HK, Morren MA, Varkonyi J, Zink A, Niedoszytko M, Niederwieser D, Malcovati L, Reiter A, Kennedy V, Gotlib J, Lortholary O, Hermine O, Arock M, Kluin-Nelemans H, Sperr WR; Study Group of the European Competence Network on Mastocytosis (ECNM).

J Allergy Clin Immunol Pract. 2019 Jan;7(1):81-87. doi: 10.1016/j.jaip.2018.09.024. Epub 2018 Nov 8. Review.

PMID:
30416055
2.

CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.

Niederkorn A, Frühauf J, Schwantzer G, Wutte N, Painsi C, Werner S, Stradner M, Berghold A, Hermann J, Aberer E.

Arch Dermatol Res. 2018 Aug;310(6):485-493. doi: 10.1007/s00403-018-1836-6. Epub 2018 May 4.

PMID:
29728857
3.

Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA.

Aberer E, Surtov-Pudar M, Wilfinger D, Deutsch A, Leitinger G, Schaider H.

Arch Dermatol Res. 2018 Mar;310(2):117-126. doi: 10.1007/s00403-017-1797-1. Epub 2017 Dec 6.

4.

Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC.

Arthritis Rheumatol. 2018 Feb;70(2):171-184. doi: 10.1002/art.40375. Review.

5.

European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.

Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T.

J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1401-1424. doi: 10.1111/jdv.14458. Epub 2017 Aug 9.

PMID:
28792092
6.

European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.

Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1581-1594. doi: 10.1111/jdv.14466. Epub 2017 Aug 8.

PMID:
28786499
7.

Adult morphea en coup de sabre with accompanying regional polymyositis: A separate entity?

Homayoon D, Haybaeck J, Aberer E.

Australas J Dermatol. 2018 May;59(2):e145-e146. doi: 10.1111/ajd.12612. Epub 2017 Jul 21. No abstract available.

PMID:
28731498
8.

Changes in pulmonary exercise haemodynamics in scleroderma: a 4-year prospective study.

Kovacs G, Avian A, Wutte N, Hafner F, Moazedi-Fürst F, Kielhauser S, Aberer E, Brodmann M, Graninger W, Foris V, Olschewski A, Olschewski H.

Eur Respir J. 2017 Jul 13;50(1). pii: 1601708. doi: 10.1183/13993003.01708-2016. Print 2017 Jul.

9.

Paraneoplastic pemphigus in two pairs of brothers.

Kranzelbinder B, Hashimoto T, Joch M, Salmhofer W, Reiter H, Bauer J, Aberer E.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):e552-e553. doi: 10.1111/jdv.14418. Epub 2017 Jul 12. No abstract available.

PMID:
28622444
10.

An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.

Sticherling M, Franke A, Aberer E, Gläser R, Hertl M, Pfeiffer C, Rzany B, Schneider S, Shimanovich I, Werfel T, Wilczek A, Zillikens D, Schmidt E.

Br J Dermatol. 2017 Nov;177(5):1299-1305. doi: 10.1111/bjd.15649. Epub 2017 Oct 29.

PMID:
28494097
11.

Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.

Schwameis M, Kündig T, Huber G, von Bidder L, Meinel L, Weisser R, Aberer E, Härter G, Weinke T, Jelinek T, Fätkenheuer G, Wollina U, Burchard GD, Aschoff R, Nischik R, Sattler G, Popp G, Lotte W, Wiechert D, Eder G, Maus O, Staubach-Renz P, Gräfe A, Geigenberger V, Naudts I, Sebastian M, Reider N, Weber R, Heckmann M, Reisinger EC, Klein G, Wantzen J, Jilma B.

Lancet Infect Dis. 2017 Mar;17(3):322-329. doi: 10.1016/S1473-3099(16)30529-1. Epub 2016 Dec 20. Erratum in: Lancet Infect Dis. 2017 Nov 21;:.

PMID:
28007428
12.

S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).

Kuhn A, Aberer E, Bata-Csörgő Z, Caproni M, Dreher A, Frances C, Gläser R, Klötgen HW, Landmann A, Marinovic B, Nyberg F, Olteanu R, Ranki A, Szepietowski JC, Volc-Platzer B.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):389-404. doi: 10.1111/jdv.14053. Epub 2016 Dec 20.

PMID:
27859683
13.

Medical Photography: Documentation, Art, and the Expression of Human Emotions.

Aberer E, Stieber W, Homayoon D, Fink-Puches R, Lichen R, Salmhofer W, Gruber-Wackernagel A, Aberer W.

Case Rep Dermatol. 2016 Sep 12;8(3):227-238. eCollection 2016 Sep-Dec.

14.

Cyclosporine Reduces Sclerosis in Morphea: A Retrospective Study in 12 Patients and a Literature Review.

Bali G, Frühauf J, Wutte N, Aberer E.

Dermatology. 2016;232(4):503-10. doi: 10.1159/000448171. Epub 2016 Aug 30. Review.

15.

Spirituality and mood pathology in severe skin conditions: a prospective observational study.

Unterrainer HF, Lukanz M, Pilch M, Scharf S, Glawischnig-Goschnik M, Wutte N, Fink-Puches R, Aberer E.

Arch Dermatol Res. 2016 Sep;308(7):521-5. doi: 10.1007/s00403-016-1672-5. Epub 2016 Jul 4.

16.

Spiritual well-being and coping in scleroderma, lupus erythematosus, and melanoma.

Pilch M, Scharf SN, Lukanz M, Wutte NJ, Fink-Puches R, Glawischnig-Goschnik M, Unterrainer HF, Aberer E.

J Dtsch Dermatol Ges. 2016 Jul;14(7):717-28. doi: 10.1111/ddg.12715.

PMID:
27373247
17.

Spirituelles Wohlbefinden und Coping bei Sklerodermie, Lupus erythematodes und malignem Melanom.

Pilch M, Scharf SN, Lukanz M, Wutte NJ, Fink-Puches R, Glawischnig-Goschnik M, Unterrainer HF, Aberer E.

J Dtsch Dermatol Ges. 2016 Jul;14(7):717-29. doi: 10.1111/ddg.12715_g.

PMID:
27373246
18.

German guidelines for the diagnosis and therapy of localized scleroderma.

Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P, Kuhn A, Aberer E, Scharffetter-Kochanek K, Horneff G, Reil E, Weberschock T, Hunzelmann N.

J Dtsch Dermatol Ges. 2016 Feb;14(2):199-216. doi: 10.1111/ddg.12724.

PMID:
26819124
19.

The influence of religious/spiritual well-being on quality of life in dermatological disease.

Unterrainer HF, Lukanz M, Pilch M, Scharf S, Glawischnig-Goschnik M, Wutte N, Fink-Puches R, Aberer E.

Br J Dermatol. 2016 Jun;174(6):1380-3. doi: 10.1111/bjd.14359. Epub 2016 Jan 28. No abstract available.

PMID:
26694685
20.

Sclerodermiform porphyria cutanea tarda after torasemide.

Kranzelbinder B, Wiednig M, El-Shabrawi-Caelen L, Aberer W, Aberer E.

Eur J Dermatol. 2015 Sep-Oct;25(5):484-5. doi: 10.1684/ejd.2015.2556. No abstract available.

PMID:
26693635
21.

Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature.

Klebes M, Wutte N, Aberer E.

Dermatology. 2016;232(1):91-6. doi: 10.1159/000441054. Epub 2015 Nov 26. Review.

22.

Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.

Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N; German Network for Systemic Scleroderma.

J Rheumatol. 2016 Jan;43(1):66-74. doi: 10.3899/jrheum.150382. Epub 2015 Nov 15.

23.

Anaphylaxis with clonal mast cells in normal looking skin - a new entity?

Bretterklieber A, Beham-Schmid C, Sturm GJ, Berghold A, Brezinschek R, Aberer W, Aberer E.

Allergy. 2015 Jul;70(7):864-72. doi: 10.1111/all.12634. Epub 2015 May 22.

PMID:
25899109
24.

Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.

Wutte N, Archelos J, Crowe BA, Zenz W, Daghofer E, Fazekas F, Aberer E.

J Neurol Sci. 2014 Dec 15;347(1-2):96-103. doi: 10.1016/j.jns.2014.09.027. Epub 2014 Sep 26.

PMID:
25288328
25.

Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses.

Bretterklieber A, Painsi C, Avian A, Wutte N, Aberer E.

BMC Res Notes. 2014 Sep 2;7:594. doi: 10.1186/1756-0500-7-594.

26.

An Arden-Syntax-based clinical decision support framework for medical guidelines--Lyme borreliosis as an example.

Seitinger A, Fehre K, Adlassnig KP, Rappelsberger A, Wurm E, Aberer E, Binder M.

Stud Health Technol Inform. 2014;198:125-32.

PMID:
24825694
27.

Disease spectrum in patients with elevated serum tryptase levels.

Aberer E, Savic S, Bretterklieber A, Reiter H, Berghold A, Aberer W.

Australas J Dermatol. 2015 Feb;56(1):7-13. doi: 10.1111/ajd.12146. Epub 2014 Feb 19.

PMID:
24575854
28.

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.

Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JH, Fierlbeck G, Genth E, Guenther C, Hein R, Henes J, Herich L, Herrgott I, Koetter I, Kreuter A, Krieg T, Kuhr K, Lorenz HM, Meier F, Melchers I, Mensing H, Mueller-Ladner U, Pfeiffer C, Riemekasten G, Sárdy M, Schmalzing M, Sunderkoetter C, Susok L, Tarner IH, Vaith P, Worm M, Wozel G, Zeidler G, Hunzelmann N; all participating DNSS centers.

Ann Rheum Dis. 2015 Apr;74(4):730-7. doi: 10.1136/annrheumdis-2013-204487. Epub 2014 Jan 3.

29.

Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.

Wiednig M, Beham-Schmid C, Kranzelbinder B, Aberer E.

Dermatology. 2013;227(1):67-71. doi: 10.1159/000351807. Epub 2013 Aug 31.

30.

Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM).

Valent P, Aberer E, Beham-Schmid C, Fellinger C, Fuchs W, Gleixner KV, Greul R, Hadzijusufovic E, Hoermann G, Sperr WR, Wimazal F, Wöhrl S, Zahel B, Pehamberger H.

Am J Blood Res. 2013 May 5;3(2):174-80. Print 2013.

31.

CXCL13 and B-cell activating factor as putative biomarkers in systemic sclerosis.

Wutte N, Kovacs G, Berghold A, Reiter H, Aberer W, Aberer E.

Br J Dermatol. 2013 Sep;169(3):723-5. doi: 10.1111/bjd.12411. No abstract available.

PMID:
23647531
32.

Livid erythematous patches on the trunk in Lyme borreliosis.

Surtov-Pudar M, Aberer E.

J Dtsch Dermatol Ges. 2013 Apr;11(4):354-5. doi: 10.1111/ddg.12018. Epub 2013 Jan 2. No abstract available.

PMID:
23279652
33.

Treatment of livedoid vasculopathy with alprostadil (PGE-1): case report and review of published literature.

Mofarrah R, Aberer W, Aberer E.

J Eur Acad Dermatol Venereol. 2013 Feb;27(2):e252-4. doi: 10.1111/j.1468-3083.2012.04480.x. Epub 2012 Feb 25. Review. No abstract available.

PMID:
22364635
34.

Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure.

Kovacs G, Maier R, Aberer E, Brodmann M, Graninger W, Kqiku X, Scheidl S, Tröster N, Hesse C, Rubin L, Olschewski H.

Arthritis Rheum. 2012 Apr;64(4):1257-62. doi: 10.1002/art.33460. Epub 2011 Nov 11.

35.

A previously unreported differential diagnosis of the complex regional pain syndrome.

Bornemann-Cimenti H, Mulzet D, Archan S, Aberer E, Rumpold-Seitlinger G, Dorn C.

Pain Med. 2011 Nov;12(11):1682-3. doi: 10.1111/j.1526-4637.2011.01244.x. Epub 2011 Oct 10. No abstract available.

PMID:
21985021
36.

Serum CXCL13 chemokine is not a marker for active Lyme borreliosis.

Wutte N, Berghold A, Krainberger I, Aberer E.

Acta Derm Venereol. 2011 Oct;91(6):724-5. doi: 10.2340/00015555-1144. No abstract available.

37.

Discontinuing long-term Iloprost treatment for Raynaud's Phenomenon and systemic sclerosis: a single-center, randomized, placebo-controlled, double-blind study.

Bali G, Schwantzer G, Aberer F, Kraenke B, Aberer E.

Acta Dermatovenerol Alp Pannonica Adriat. 2011;20(1):13-21.

38.

Calcinosis cutis: part II. Treatment options.

Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E.

J Am Acad Dermatol. 2011 Jul;65(1):15-22; quiz 23-4. doi: 10.1016/j.jaad.2010.08.039. Review.

PMID:
21679811
39.

Calcinosis cutis: part I. Diagnostic pathway.

Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E.

J Am Acad Dermatol. 2011 Jul;65(1):1-12; quiz 13-4. doi: 10.1016/j.jaad.2010.08.038. Review.

PMID:
21679810
40.

CXCL13 chemokine in pediatric and adult neuroborreliosis.

Wutte N, Berghold A, Löffler S, Zenz W, Daghofer E, Krainberger I, Kleinert G, Aberer E.

Acta Neurol Scand. 2011 Nov;124(5):321-8. doi: 10.1111/j.1600-0404.2010.01477.x. Epub 2011 Feb 15.

PMID:
21320077
41.

Within European margins.

Aberer E, Fingerle V, Wutte N, Fink-Puches R, Cerroni L.

Lancet. 2011 Jan 8;377(9760):178. doi: 10.1016/S0140-6736(10)62241-6. No abstract available.

PMID:
21215884
42.

Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus.

Aberer E.

Lupus. 2010 Aug;19(9):1118-24. doi: 10.1177/0961203310370348. Review.

PMID:
20693206
43.

Subcutaneous morphea with dystrophic calcification with response to ceftriaxone treatment.

Reiter N, El-Shabrawi L, Leinweber B, Aberer E.

J Am Acad Dermatol. 2010 Aug;63(2):e53-5. doi: 10.1016/j.jaad.2009.11.016. No abstract available.

PMID:
20633791
44.

Pseudolymphomatous tumid lupus erythematosus of the oral mucosa.

Tallon B, Kaddu S, Cerroni L, Kerl H, Aberer E.

Am J Dermatopathol. 2010 Oct;32(7):704-7. doi: 10.1097/DAD.0b013e3181d0d1f9.

PMID:
20559118
45.

[Lupus erythematosus. Wide range of symptoms through clinical variation, associated diseases and imitators].

Aberer E.

Hautarzt. 2010 Aug;61(8):676-82. doi: 10.1007/s00105-010-1939-2. Review. German.

PMID:
20549478
46.

Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization.

Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Hesse C, Troester N, Salmhofer W, Stauber R, Fuerst FC, Thonhofer R, Ofner-Kopeinig P, Gruenig E, Olschewski H.

Chest. 2010 Aug;138(2):270-8. doi: 10.1378/chest.09-2099. Epub 2010 Apr 23.

PMID:
20418368
47.

Management of an unfortunate triad after breast reconstruction: pyoderma gangrenosum, full-thickness chest wall defect and Acinetobacter Baumannii Infection.

Schintler MV, Grohmann M, Donia C, Aberer E, Scharnagl E.

J Plast Reconstr Aesthet Surg. 2010 Jul;63(7):e564-7. doi: 10.1016/j.bjps.2009.12.013. Epub 2010 Feb 11.

PMID:
20153277
48.

Schnitzler syndrome: response to anakinra in two cases and a review of the literature.

Schuster C, Kränke B, Aberer E, Arbab E, Sturm G, Aberer W.

Int J Dermatol. 2009 Nov;48(11):1190-4. doi: 10.1111/j.1365-4632.2009.04151.x. Review.

PMID:
20064173
49.

Erythematous macules in a 14-year-old girl.

Massone C, Kopera D, Aberer E.

Clin Exp Dermatol. 2010 Jan;35(1):101-2. doi: 10.1111/j.1365-2230.2009.03233.x. No abstract available.

PMID:
20028408
50.

Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma.

Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Tröster N, Hesse C, Salmhofer W, Graninger W, Gruenig E, Rubin LJ, Olschewski H.

Am J Respir Crit Care Med. 2009 Nov 1;180(9):881-6. doi: 10.1164/rccm.200904-0563OC. Epub 2009 Aug 13.

PMID:
19679693

Supplemental Content

Loading ...
Support Center